Research Tree Research Tree Logo

  • Try our Investor Tool
  • Login
  • Sign Up

Research Tree Logo

  • Login
  • Sign Up
  • Features
  • Pricing
  • RNS/News
  • Contact
  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies
⨯
  • Providers
  • Companies
⨯
  • Features
  • Pricing
  • Event Hub
  • RNS/News
  • Short Interest
  • Contact
Blogs >
The Naked Fund Manager >
CFD platforms still worth a look
  • 06 Mar 17
title

CFD platforms still worth a look

  • 2919 views
The Naked Fund Manager

UK-focused Small and Mid-cap fund manager.

 
CFD platforms
Strap line

PE multiples have partially converged but range is still wide. FCA consultation ends tomorrow.

Companies: CMCX, IGG, PLUS


Body

 

Afternoon all,


Back to school, and yet another strong week for equity markets. Thanks to Rob for filling in for me with his excellent piece on Purplebricks.


I thought I would revisit the CFD platforms this week. I wrote about them in one of my earlier blogs last year, and a lot has happened since then. They’ve all performed very nicely, and PLUS has been on a tear, although it was starting from such a low base this should not have been a surprise. As mentioned before, I am a holder of these companies.


 

Massive PLUS dividend last week - Be careful of the tax!

Before reviewing the lie of the land for the CFD platforms, I want to point out the giant Plus 500 dividend that went "ex" last week. The critical detail I want to highlight to all readers who hold shares, as we do, is that you will be charged 25% tax on your dividend unless you apply to the Israel Tax Authority (ITA) and obtain a certificate for a reduced withholding tax rate of 15%. The shares went ex-dividend on the 2nd March.


Here’s the form from the ITA: https://taxes.gov.il/English/TaxesFormsList/itca114.pdf


For more detail on the Israeli withholding tax process, there is a useful article here from 2014:


 

PLUS has outperformed CMC and IGG since drop

All three CFD providers have been good performers since the original slide in share prices following the announcements from the FCA and other regulators in early December. However, PLUS has been the standout performer of the three with a 29% rise in share price, versus 9%/10% for the other two.


CFD platforms IGG PLUS and CMCX share price performance since FCA bombshell

I would just point out that I’ve incorporated the 53p dividend from PLUS that went ex last week (after stripping 15% withholding tax from the gross amount). Even net of tax, that still equated to a lovely c.10% dividend yield. I would not expect this level of special dividends (22p of the 53p) to continue now there is significant regulatory uncertainty.


 

How did the Brokers react

Consensus forecasts for all three CFD platforms took a hammering after the regulatory announcements with a moderate hit to 2017 earnings and a bigger hit in 2018, which will be the first full year to be affected by any changes that may be coming.


Below is a chart showing consensus EPS forecasts for 2018 and how they changed post the FCA announcement.


EPS forecast changes for IG, PLUS and CMC Markets post FCA consultation

As you can see, analysts were far more aggressive in their cuts to forecasts for CMC and PLUS, whose numbers came down 44% and 40% respectively, than they were for IG, whose 2018 consensus EPS estimates reduced 23%.


Part of this could be a perception that IG is the market leader, certainly in the UK, and it operates further up the quality chain than PLUS. This is probably fair.

 

However, another factor which I think we could be seeing here is the difference in coverage depth. PLUS and CMC both have fewer analysts covering them than c.£2bn market cap IG Group. Therefore consensus will have more of a weighting from the corporate brokers. These analysts may well err more on the side of conservatism in the face of an uncertain conclusion to the consultation period. Analysts much prefer to increase forecasts into good news and a recovery.


 

Finally what multiples has the market been discounting

I looked at the 2018 price-to-earnings multiple the market has been applying to each of the CFD platforms and how that has evolved over time, starting about a week before the regulatory bombshells hit.

 

PE evolution for PLUS IGG and CMCX before and during FCA consultation period 2016 2017

Interesting conclusions to be drawn from the above chart:

 

  • There was a severe differential in the multiple the market was willing to give each CFD player before the regulatory bombshell. IGG was the premium stock trading at around 16x 2018 earnings. CMC was only given a 10x rating which is mainly due to previous recent profit warnings. Plus 500 was the lowest rated by the market at a lowly 7x 2018 forecast earnings, primarily due to the significant issues it had already faced with the FCA.
  • After the regulatory announcements, IG’s valuation took a knock dropping to 11x before climbing to 13x today. The CMC multiple barely moved. Plus 500 briefly fell as low as 6x earnings but has since rallied strongly to 9.4x today.

Overall there has been a converging of multiples. However, there is still a sizeable c.40% gap between the valuation placed on IG shares and that placed on PLUS shares. Furthermore, the multiples are based on Plus 500’s consensus earnings forecasts that were slashed 40%, compared to IG’s falling 23%.


 

Cash on the Balance Sheet should be accounted for

My analysis of P/E multiples above doesn’t account for the amount of cash on the Balance Sheets, which is a further reason why I like these companies.


IG Group and PLUS are both generating lots of cash but are also sitting on large cash balances, CMC slightly less so. It is important to strip out client cash which all three do clearly in their Financial Statements. After removing client funds from the equation, IG is sitting on a cash pile of c.£220m (July 2016 Results), CMC has £42m, and PLUS had an enormous $136m at year end. When compared to the market caps of £2bn for IG, £350m for CMC and £490m for PLUS, that’s a lot of excess cash.


Analysis of the earnings multiple discounted by the market should strip out this excess cash first, which would put the three on even lower multiples.


 

Consultation period to close tomorrow - what next?

The FCA’s consultation period runs until the 7th March, i.e., tomorrow. All comments must be submitted before the deadline, and then the Policy Statement is scheduled to be released in “Spring 2017”. This gives the FCA until mid-June 2017 to digest the various views of key players and come to a decision.


As highlighted by a number of analysts, there is a real risk of regulatory arbitrage should the FCA and the other regulators (e.g., BaFin) decide upon very different measures. I would expect the FCA’s decision to take the actions of the other regulators into account.


The only real catalyst that matters over the coming months is the decisions of the various regulators, particularly the FCA and BaFin. Any move by the FCA towards the other regulators’ position of a preference for limited risk accounts rather than onerous leverage caps would be a significant positive for all CFD platforms.

 

 

-----

 

To read a brief outline of how I think about stocks, and what I aim to achieve in this blog, please check out my first blog where I set out my stall.

 

Recent blogs:

  • 27 Feb 17 - Purplebricks US expansion: How big is the opportunity?
  • 20 Feb 17 - M&A - One reason why I’m still bullish on UK equities
  • 14 Feb 17 - Anatomy of a growth company
  • 6 Feb 17 - Roll-outs: the Good, the Bad and the Ugly
  • 30 Jan 17 - How MiFID II could hurt Small and Mid-caps
  • 23 Jan 17 - Why Pearson was an obvious value trap, and is Jackpotjoy worth a closer look?
  • 16 Jan 17 - How sustainable are current dividends
  • 8 Jan 17 - Implications of Trumponomics for equities
  • 18 Dec 16 - Millennials - Becoming the most important demographic
  • 12 Dec 16 - CFDs - Tough week but worth a closer look
  • 5 Dec 16 - Pension deficit dogs starting to look interesting
  • 28 Nov 16 - Setting out my stall...plus my thoughts on bond proxies 

Please Note: To be clear, I do not and will not ever give any advice. I will rarely mention individual stocks but when I do these will not be recommendations, instead just my thoughts at that point in time.

 


Body Two

Body Three

Body Four

Body Five

The information contained within this post is based on personal experience and opinion and should not be considered as a recommendation to trade nor financial advice.

More Content

More Content

Looking Ahead – w/c 15th Feb 2021

Companies: ARBBTRIWILCLIGGATCAEGNWGWJGMRLK3CRBGONCSENSMANOPLUSGLEN

Research Tree

CMC Markets PLC's Peter Cruddas says investment in tech underpins profits surge

Companies: CMC Markets Plc

Proactive

CMC Markets' promote 'love, trust and support' with new £600K charity programme

Companies: CMC Markets Plc

Proactive

Most popular equity research this week | 28 May - 8 Jun

Companies: BNOCMHRE/SCEARBBSIXHPHTMTONVP/APHMURAGYSXXALTCLIGINLGDRTRXSCLPCOSKWSTIMEAVODNLOXBRFXKOOVYGENABZANSFREDXEVGVALGTLYPHPAVCTMCLBURPLUSB90

Research Tree

CMC Markets' reports record six months, targeting high value clients and investing in technology

Companies: CMC Markets Plc

Proactive
next
 

Useful Links

  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub

Account

  • Login
  • Free Trial - Join Now
  • Contact
Follow us on Linkedin Follow us on Twitter

Share:

Heap | Mobile and Web Analytics

Copyright © 2021 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • RNS/News
  • Short Interest Tracker
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Leisure, Tourism & Travel
      • Media
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Align Research
      • BRR Media
      • Capital Access Group
      • Couloir Capital
      • Edison
      • Equity Development
      • eResearch
      • Exane BNP Paribas - Sponsored Research
      • Fidante Partners
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hardman & Co
      • Independent Investment Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Mello Events
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • QuotedData
      • RaaS - Research as a Service
      • Radnor Capital Partners
      • Research Tree
      • SEAL Advisors Ltd
      • ShareSoc
      • Trinity Delta
      • Yellowstone Advisory
    • High Net Worth Offering
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Cenkos Securities
      • Couloir Capital
      • Dowgate Capital
      • Exane BNP Paribas - Sponsored Research
      • finnCap
      • First Berlin
      • Hybridan
      • Liberum
      • Longspur Research
      • Louis Capital
      • Medley Global Advisors
      • N+1 Singer
      • Northland Capital Partners
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • The Life Sciences Division
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BRR Media
      • Bryan, Garnier & Co
      • Capital Access Group
      • Cenkos Securities
      • Couloir Capital
      • Dowgate Capital
      • Edison
      • Equity Development
      • eResearch
      • Exane BNP Paribas
      • Exane BNP Paribas - Sponsored Research
      • Fidante Partners
      • finnCap
      • First Berlin
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hardman & Co
      • Hybridan
      • Independent Investment Research
      • InterAxS Global
      • Kepler | Absolute Hedge
      • Kepler | Trust Intelligence
      • Liberum
      • London Stock Exchange
      • Longspur Research
      • Mello Events
      • N+1 Singer
      • Northland Capital Partners
      • Numis
      • Peel Hunt
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • QuotedData
      • RaaS - Research as a Service
      • Radnor Capital Partners
      • Research Tree
      • SEAL Advisors Ltd
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • The Life Sciences Division
      • Trinity Delta
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Video/Audio Interviews
      • BRR Media
      • Capital Access Group
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • piworld.co.uk
      • Proactive
      • Research Tree
      • Yellowstone Advisory
    • Event Providers
      • Capital Access Group
      • Cenkos Securities
      • Equity Development
      • Hardman & Co
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Mello Events
      • piworld.co.uk
      • QuotedData
      • ShareSoc
      • VSA Capital
      • Yellowstone Advisory
  • Contact
  • Sign Up
  • Sign In